z-logo
Premium
Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders
Author(s) -
Ögmundsdóttir H. M.,
Hilmarsdóttir H.,
Björnsson J.,
Holbrook W. P.
Publication year - 2009
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.2009.00767.x
Subject(s) - hyperkeratosis , leukoplakia , medicine , oral lichen planus , cancer , biopsy , pathology , carcinoma , dermatology , lesion , keratosis , dyskeratosis
Objectives:  In a previous cross‐sectional study, the authors found a higher rate of TP53 mutation in oral lichen planus (OLP) than in hyperkeratosis. By analysing for TP53 mutations in serial samples from patients on long‐term follow‐up of their oral lesions, it was hoped to determine if these mutations were related to disease progression. Methods:  Eight patients presenting with lesions diagnosed clinically as oral leukoplakia or lichen planus were followed from 2 to 12 years. Two to five samples of archival biopsy tissue were analysed from each patient by constant denaturant gradient gel electrophoresis for hotspots A, B, C, D and exon 6. Results:  Four patients were diagnosed clinically as OLP: two of these were confirmed histopathologically, one was diagnosed as non‐specific hyperkeratosis and one as cancer. Four patients had leukoplakia only, with a histopathological diagnosis of hyperkeratosis. Seven patients had TP53 mutations, three of them on repeated occasions. All five patients who developed squamous‐cell carcinoma had mutations. Two of them had mutated pre‐malignant lesions, and one of these previously had a non‐mutated cancer. Three patients had two different primary cancers, only one of them mutated. One patient developed a mutated cancer 5 years after the last mutation‐free biopsy. Of the cancer‐free patients, a lesion regarded clinically as cancer‐suspicious in one case was mutated, in another patient two OLP lesions were mutated, the third had five biopsies taken during 8 years, all non‐mutated. Conclusions:  TP53 mutations may occur early or late in the development of oral squamous‐cell carcinoma.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom